Overview
Federated Co-operatives Limited (FCL), based in Saskatoon, is Canada’s largest non-financial co-operative and one of the country’s top petroleum marketers. With over 780 fueling locations and 500+ contaminated sites, FCL faces major environmental and financial liabilities from petroleum hydrocarbon impacts.
Many FCL-owned sites are anoxic and contain deep, mixed plumes that are impractical to remediate by excavation or soil vapour extraction. One such plume in Dryden, Ontario, has persisted for decades and could expose FCL to regulatory penalties, lawsuits, and reputational damage if not addressed.
Bioremediation offers a lower-cost, sustainable treatment option by harnessing microorganisms that degrade hydrocarbons in situ, but reliable tools to assess anaerobic biodegradation are lacking. To address this gap, FCL is partnering with Prof. Elizabeth Edwards (a world expert in anaerobic bioremediation) and SiREM (an Ontario-based bioremediation service provider) to validate genomics-enabled tools at Dryden and other field sites by directly tracking hydrocarbon-degrading microorganisms and linking their abundance and activity to degradation rates.
This project will deliver the first validated genomic framework to quantify and monitor anaerobic hydrocarbon biodegradation. The innovation integrates: (1) deep multi-omics sequencing to identify active anaerobic degraders; (2) quantitative PCR biomarker assays for widespread degraders and functional genes; and (3) predictive models to estimate site-specific biodegradation rates and guide remediation decisions.
By advancing genomic tools and sharing results with Canadian stakeholders and regulators, FCL will reduce uncertainty and costs at its own sites while supporting a new industry standard for anaerobic bioremediation. The benefits to FCL are immediate and substantial. Validated genomic tools will reduce long-term monitoring costs (often $20–60K per site annually), accelerate closure of challenging sites, and lower liabilities across FCL’s portfolio, with potential savings in the millions.
The Canadian remediation market is valued at over $2B, and site owners of the tens of thousands of BTEX-contaminated sites across the country also stand to benefit through significant cost savings. Regulators will gain transparent, evidence-based data that strengthen compliance and reduce uncertainty in remediation planning.
Nationally, the project will expand markets for advanced molecular bioremediation technologies, including biomarker assays and bioaugmentation cultures offered by SiREM. Broader benefits include cleaner groundwater, reduced health risks, and employment growth in Canada’s environmental sector. By leading this innovation, FCL – in partnership with Prof. Edwards and SiREM – will set a national precedent for sustainable remediation while continuing to invest in the health and resilience of the communities it serves.